Test 2 Flashcards
Indications for Metronidazole
Amebiasis, Giardiasus, trichomoniasis – used in combination with a luminal amebicide to kill gut infection
MOA for metronidazole
Some bacteria and protozoans metabolize the reactive nitro group on drug, leading to disruption of DNA repair and synthesis
Indications for niclosamide
intestinal Cestodes. Minimal indications, stays in gut (some GI)
Indications for praziquantel
All cestodes and trematodes. GI upset, some CNS effects
MOA for niclosamide
inhibits worm glucose uptake and anaerobic metabolism
MOA for praziquantel
Worm permeability to Ca increased - spastic paralysis of worm
Indications for mebendazole
GI upset, many nematodes, including pin worm (most common US helminth infection)
MOA for mebendazole
Disruption of worm microtubules
Indications for lamivudine
HBV
MOA for lamivudine
inhibits reverse transcriptase from converting viral DNA to RNA for transcription and replication
Indication for Entecavir
HBV
MOA for Entecavir
Inhibits reverse transcriptase from converting viral DNA to RNA for tarnscription and replication
Indication for Adefovir
HBV
MOA for Adefovir
Inhibit reverse transcriptase from converting viral DNA to RNA for transcription and replication
Indication for Tenofovir
HBV
MOA for Tenofovir
Inhibits reverse transcriptase from converting viral DNA to RNA for transcription and replication
Indication for Telbivudine
HBV
MOA for Telbivudine
Inhibits reverse transcriptase from converting viral DNA to RNA for transcription and replication
Indication for Boceprevir
HCV
MOA for Boceprevir
Binds to NS3 on the hep C virus
Indications for Telaprevir
HCV
MOA for Telaprivir
Bind to Ns3 on the hep C virus
Indication for Simeprevir
HCV
MOA for ismeprivir
Direct-acting antiviral treatment
indication for sofosbuvir
HCV
MOA for sofosbuvir
Inhibits HCV Ns5b (an RNA polymerase)
Indication for Ribavirin
HCV
MOA for Ribavirin
Inhibits replication of DNA and RNA viruses, used as a part of a multi therapy for hepatitis
indications for rIFN Alpha
HCV
MOA for rIFN Alpha
Increases immunological cytotoxicity for cells infected with viruses
Indication for Loperamide
Diarrhea
MOA for Loperamide
Inhibits peristalsis by acting on smooth and longitudinal layers for muscles in the GI tract
Indications for Octreotide
Diarrhea (Especially in cancer)
MOA for Octreotide
Mimics somatostatin to inhibit serotonin release along with gastrin to decrease motility
Indications for Dicyclomine
Functional Bowel Disease and IBS
MOA for Dicyclomie
Blocks ACh at parasympathetic sites in smooth muscle reducing motility
Indication for Methylcellulose
Constipation (Maybe diarrhea)
MOA for Methylcelluloase
Draws water into stool to produce a greater volume and motility
Indication for Magnesium Salts
Laxative
MOA for Magnesium Salts
Draws water into stool to produce a greater volume and motility
Indication for Bisacodyl
Constipation
MOA for Bisacodyl
Stimulates peristalsis by irritating smooth muscle of the intestine altering water and electrolyte secretion
Indication for Polyethylene Glycol
Constipation
MOA for Polyethylene Glycol
Causes retention of water in stool, increasing frequency
Indication for Lubiprostone
Idiopathic constipation, opiod, IBD
MOA for Lubiprostone
Acts on the apical surface of membrane cells to increase secretion of chloride into the lumen, increasing osmolarity and adding water to the stool
Indication for Methylnaltrexone
Opiod induced constipation
MOA for methlynaltrexone
Inhibits gastric motility induced by the presence of opiods
Indications for Psyllium
Constipation, Diarrhea
MOA for Psyllium
Soluble fiber that absorbs water in the lumen to increase the movement and bulk of stool
Indication for Bismuth Subsalicylate
Mild Diarrhea, H. pylori
MOA Bismuth subsalicylate
Anti-inflammatory and antisecretory effects on the intestinal epithelium
indication for Sulfasalazine (5-ASA derivative)
IBD, UC, Crohn’s, RA
MOA for Sulfasalazine (5-ASA derivative)
Modify Arachaidonic acid metabolism by blocking the conversion to luekotrienes and protaglandins – also seen to have inhibitory effects on Il-1 and has scavenging effect on superoxide radical
Indication for Olsalazine (5-ASA derivative)
IBD, UC, Crohns
MOA for Olsalazine (5-ASA derivative)
Modify Arachaidonic acid metabolism by blocking the conversion to luekotrienes and protaglandins – also seen to have inhibitory effects on Il-1 and has scavenging effect on superoxide radical
Indication for Mesalazine/Mesalamine (5-ASA)
IBD, UC, Crohn
MOA for Mesalazine/Mesalamine
Modify Arachaidonic acid metabolism by blocking the conversion to luekotrienes and protaglandins – also seen to have inhibitory effects on Il-1 and has scavenging effect on superoxide radical
Indications for Budesonide (Corticosteroid)
Crohns, UC
MOA for Budesonide
Controls rate of protein synthesis, depresses migrate of PMNs, anti-inflammatory
Indications for Azathioprine (Immunosuppressant, Mercaptopurine derivative)
UC, Crohns
MOA for Azathioprine
Metabolites incorporated into replicating DNA and halt replication, block purine synthesis)
Indications for 6-Mercaptopurine (Immunosuppressant, Mercaptopurine derivative)
UC, Crohns
MOA for 6-Mercaptopurine
Metabolites incorporated into replicating DNA and halt replication, block purine synthesis)
Indication for infliximab (TNF-alpha inhibitor)
Crohn, UC
MOA for infliximab
Chimeric monoclonal antibody that binds to TNF-alpha interfering with its activity
Indication for Adalimumab (TNF-alpha inhibitor)
Crohn, UC
MOA for Adalimumab
Chimeric monoclonal antibody that binds to TNF-alpha interfering with its activity
Indication for Certolizumab (TNF-alpha inhibitor)
Crohn, UC
MOA for Certolizumab
Chimeric monoclonal antibody that binds to TNF-alpha interfering with its activity